November 8, 2021
Takeda Pharmaceutical’s proton pump inhibitor (PPI) Takecab (vonoprazan) edged out Ono Pharmaceutical’s PD-1 inhibitor Opdivo (nivolumab) to become the No. 1 drug in Japan in October, according to a monthly snapshot report released by Encise. Takecab raked in 10 billion...read more